It has been postulated that the metabolic environment of T2D, characterised by hyperglycaemia and hyperinsulinaemia, is a key activator of the NLRP3 inflammasome, particularly given its upregulation in this population [81]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.